Deborah A. Bowen

4.2k total citations
66 papers, 2.6k citations indexed

About

Deborah A. Bowen is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Deborah A. Bowen has authored 66 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Genetics, 44 papers in Pathology and Forensic Medicine and 26 papers in Immunology. Recurrent topics in Deborah A. Bowen's work include Chronic Lymphocytic Leukemia Research (55 papers), Lymphoma Diagnosis and Treatment (41 papers) and Immunodeficiency and Autoimmune Disorders (26 papers). Deborah A. Bowen is often cited by papers focused on Chronic Lymphocytic Leukemia Research (55 papers), Lymphoma Diagnosis and Treatment (41 papers) and Immunodeficiency and Autoimmune Disorders (26 papers). Deborah A. Bowen collaborates with scholars based in United States, United Kingdom and France. Deborah A. Bowen's co-authors include Neil E. Kay, Clive S. Zent, Timothy G. Call, Tait D. Shanafelt, Susan L. Slager, Susan M. Schwager, Diane F. Jelinek, Betsy LaPlant, Curtis A. Hanson and José F. Leis and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Deborah A. Bowen

64 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deborah A. Bowen United States	28	1.4k	1.3k	847	647	627	66	2.6k
Mario Bargetzi Switzerland	26	425 0.3×	686 0.5×	281 0.3×	747 1.2×	324 0.5×	91	2.3k
Félix Couture Canada	26	233 0.2×	334 0.3×	304 0.4×	648 1.0×	491 0.8×	84	2.3k
Hugo F. Fernández United States	35	755 0.5×	233 0.2×	523 0.6×	3.6k 5.6×	1.6k 2.6×	172	4.9k
Lotus Mallbris United States	40	142 0.1×	631 0.5×	3.5k 4.2×	467 0.7×	434 0.7×	96	4.8k
Manisha Bhutani United States	27	192 0.1×	294 0.2×	185 0.2×	964 1.5×	1.0k 1.6×	144	2.8k
Richard L. Haspel United States	23	259 0.2×	81 0.1×	652 0.8×	569 0.9×	986 1.6×	75	2.4k
Cindy N. Roy United States	27	1.7k 1.2×	92 0.1×	148 0.2×	2.2k 3.4×	289 0.5×	39	3.3k
Michael C. Cox United States	23	239 0.2×	545 0.4×	240 0.3×	119 0.2×	492 0.8×	53	2.7k
Massimo Offidani Italy	32	304 0.2×	241 0.2×	231 0.3×	2.0k 3.1×	1.4k 2.2×	145	3.1k
Leon Bernal‐Mizrachi United States	16	94 0.1×	467 0.4×	270 0.3×	206 0.3×	719 1.1×	46	1.7k

Countries citing papers authored by Deborah A. Bowen

Since Specialization

Citations

This map shows the geographic impact of Deborah A. Bowen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah A. Bowen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah A. Bowen more than expected).

Fields of papers citing papers by Deborah A. Bowen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah A. Bowen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah A. Bowen. The network helps show where Deborah A. Bowen may publish in the future.

Co-authorship network of co-authors of Deborah A. Bowen

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah A. Bowen. A scholar is included among the top collaborators of Deborah A. Bowen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah A. Bowen. Deborah A. Bowen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Strati, Paolo, Mark C. Lanasa, Timothy G. Call, et al.. (2016). Ofatumumab monotherapy as a consolidation strategy in patients with previously untreated chronic lymphocytic leukaemia: a phase 2 trial. The Lancet Haematology. 3(9). e407–e414. 12 indexed citations

Zent, Clive S., Deborah A. Bowen, Michael Conte, Betsy LaPlant, & Timothy G. Call. (2015). Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with everolimus (RAD001) and alemtuzumab: a Phase I/II study. Leukemia & lymphoma. 57(7). 1585–1591. 11 indexed citations

Zent, Clive S., Timothy G. Call, Deborah A. Bowen, et al.. (2015). Early treatment of high risk chronic lymphocytic leukemia with alemtuzumab, rituximab and poly-(1-6)-beta-glucotriosyl-(1-3)- beta-glucopyranose beta-glucan is well tolerated and achieves high complete remission rates. Leukemia & lymphoma. 56(8). 2373–2378. 22 indexed citations

Bowen, Deborah A., Kari G. Rabe, Susan M. Schwager, et al.. (2014). Infectious lymphadenitis in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: a rare, but important, complication. Leukemia & lymphoma. 56(2). 311–314. 13 indexed citations

Shanafelt, Tait D., Timothy G. Call, Clive S. Zent, et al.. (2012). Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia. Cancer. 119(2). 363–370. 136 indexed citations

Shanafelt, Tait D., Neil E. Kay, Kari G. Rabe, et al.. (2011). Hematologist/oncologist disease‐specific expertise and survival: Lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL). Cancer. 118(7). 1827–1837. 28 indexed citations

Zent, Clive S., Bruce A. Smith, Zuhair K. Ballas, et al.. (2011). Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia. Leukemia & lymphoma. 53(2). 211–217. 70 indexed citations

Shanafelt, Tait D., Kari G. Rabe, Neil E. Kay, et al.. (2010). Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemia. Leukemia & lymphoma. 51(7). 1233–1240. 18 indexed citations

Bowen, Deborah A., Timothy G. Call, Tait D. Shanafelt, et al.. (2010). Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone. Leukemia & lymphoma. 51(4). 620–627. 48 indexed citations

10.

Zent, Clive S., Wei Ding, Megan S. Reinalda, et al.. (2009). Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis. Leukemia & lymphoma. 50(8). 1261–1268. 52 indexed citations

11.

Zent, Clive S., Wei Ding, Susan M. Schwager, et al.. (2008). The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma. British Journal of Haematology. 141(5). 615–621. 78 indexed citations

12.

Zent, Clive S., Timothy G. Call, Tait D. Shanafelt, et al.. (2008). Early treatment of high‐risk chronic lymphocytic leukemia with alemtuzumab and rituximab. Cancer. 113(8). 2110–2118. 62 indexed citations

13.

Shanafelt, Tait D., Deborah A. Bowen, Susan L. Slager, et al.. (2008). The physician–patient relationship and quality of life: Lessons from chronic lymphocytic leukemia. Leukemia Research. 33(2). 263–270. 36 indexed citations

14.

Hanson, Curtis A., Clive S. Zent, Luis F. Porrata, et al.. (2008). Prognostic importance of T and NK‐cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia. British Journal of Haematology. 141(5). 607–614. 68 indexed citations

15.

Thurmes, Paul J., Timothy G. Call, Susan L. Slager, et al.. (2008). Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia. Leukemia & lymphoma. 49(1). 49–56. 141 indexed citations

16.

Bowen, Deborah A., Timothy G. Call, G. Douglas Jenkins, et al.. (2007). Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features. Leukemia & lymphoma. 48(12). 2412–2417. 70 indexed citations

17.

Shanafelt, Tait D., Deborah A. Bowen, Susan L. Slager, et al.. (2007). Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients. British Journal of Haematology. 139(2). 255–264. 100 indexed citations

18.

Slager, Susan L., Clive S. Zent, Megan S. Reinalda, et al.. (2007). Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia. British Journal of Haematology. 139(3). 398–404. 65 indexed citations

19.

Aiello, Erin J., Yutaka Yasui, Shelley S. Tworoger, et al.. (2004). Effect of a yearlong, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopausal women. Menopause The Journal of The North American Menopause Society. 11(4). 382–388. 102 indexed citations

20.

Wolter, Troy D., et al.. (2001). A Free Smoking Intervention Clinic Initiated by Medical Students. Mayo Clinic Proceedings. 76(2). 144–151. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact